{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:25:26Z","timestamp":1761560726305,"version":"3.41.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1023\/a:1008931708716","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T17:46:35Z","timestamp":1040579195000},"page":"249-255","source":"Crossref","is-referenced-by-count":39,"title":["NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease"],"prefix":"10.1007","volume":"11","author":[{"given":"Patricia F.","family":"Coogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Louik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann G.","family":"Zauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Stolley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Strom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"255531_CR1","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/jnci\/90.21.1609","volume":"90","author":"MM Taketo","year":"1998","unstructured":"Taketo MM (1998) Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Cancer Inst\n90: 1609\u20131620.","journal-title":"J Natl Cancer Inst"},{"key":"255531_CR2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3835(84)80035-X","volume":"25","author":"M Pollard","year":"1984","unstructured":"Pollard M, Luckert PH (1984) Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea. Cancer Lett\n25: 117\u2013121.","journal-title":"Cancer Lett"},{"key":"255531_CR3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF02553001","volume":"27","author":"U Metzger","year":"1984","unstructured":"Metzger U, Meier J, Uhlschmid G, Weihe H (1984) Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer. Dis Colon Rectum\n27: 366\u2013369.","journal-title":"Dis Colon Rectum"},{"key":"255531_CR4","first-page":"2562","volume":"50","author":"BS Reddy","year":"1990","unstructured":"Reddy BS, Nayini J, Tokumo R, Rigotty J, Zang E, Kello. G (1990) Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal anti-inflammatory drug with D,L-alpha-difluoromethylorithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res\n50: 2562\u20132568.","journal-title":"Cancer Res"},{"key":"255531_CR5","first-page":"556","volume":"2","author":"SK Boolbol","year":"1996","unstructured":"Boolbol SK, Dannenberg AJ, Chaburn A, et al. (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res\n2: 556\u2013560.","journal-title":"Cancer Res"},{"key":"255531_CR6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jnci\/83.5.355","volume":"83","author":"L Rosenberg","year":"1991","unstructured":"Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S (1991) A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large bowel cancer. J Natl Cancer Inst\n83: 355\u2013358.","journal-title":"J Natl Cancer Inst"},{"key":"255531_CR7","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q","volume":"82","author":"L Rosenberg","year":"1998","unstructured":"Rosenberg L, Louik C, Shapiro S (1998) Nonsteroidal antiflammatory drug use and reduced risk of large bowel carcinoma. Cancer\n82: 2326\u20132333.","journal-title":"Cancer"},{"key":"255531_CR8","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D","volume":"72","author":"O Suh","year":"1993","unstructured":"Suh O, Mettlin C, Petrelli NJ (1993) Aspirin use, cancer, and polyps of the large bowel. Cancer\n72: 1171\u20131177.","journal-title":"Cancer"},{"key":"255531_CR9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-121-4-199408150-00001","volume":"121","author":"E Giovannucci","year":"1994","unstructured":"Giovannucci E, Rim EB, Stampfer MJ, Colditz A, Ascherio A, Willett WC (1994) Aspirin use and the risk of colorectal cancer and adenoma in male health professionals. Ann Intern Med\n121: 241\u2013246.","journal-title":"Ann Intern Med"},{"key":"255531_CR10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199509073331001","volume":"333","author":"E Giovannucci","year":"1995","unstructured":"Giovannucci E, Egan K, Hunter DJ, et al. (1995) Aspirin and the risk of colorectal cancer in women. N Engl J Med\n333: 609\u2013614.","journal-title":"N Engl J Med"},{"key":"255531_CR11","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","volume":"325","author":"MJ Thun","year":"1991","unstructured":"Thun MJ, Namboordi MM, Heath CW Jr (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med\n325: 1593\u20131596.","journal-title":"N Engl J Med"},{"key":"255531_CR12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJM199509073331011","volume":"333","author":"AJ Marcus","year":"1995","unstructured":"Marcus AJ (1995) Aspirin as prophylaxis against colorectal cancer. [Editorial]. N Engl J Med\n333: 656\u2013658.","journal-title":"N Engl J Med"},{"key":"255531_CR13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/oxfordjournals.epirev.a036132","volume":"15","author":"JD Potter","year":"1993","unstructured":"Potter JD, Slattery ML, Bostick RM, Gapstur SM (1993) Colon cancer: a review of the epidemiology. Epidemiol Rev\n15: 499\u2013545.","journal-title":"Epidemiol Rev"},{"key":"255531_CR14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/oxfordjournals.epirev.a036154","volume":"16","author":"LA Peipins","year":"1994","unstructured":"Peipins LA, Sandler RS (1994) Epidemiology of colorectal adenomas. Epidemiol Rev\n16: 273\u2013297.","journal-title":"Epidemiol Rev"},{"key":"255531_CR15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1469-1809.1992.tb01136.x","volume":"56","author":"RS Houlston","year":"1992","unstructured":"Houlston RS, Collins A, Slack J, Morton NE (1992) Dominant genes for colorectal cancer are not rare. Ann Hum Genet\n56: 99\u2013103.","journal-title":"Ann Hum Genet"},{"key":"255531_CR16","first-page":"301","volume-title":"Pharmacoepidemiology","author":"S Shapiro","year":"1994","unstructured":"Shapiro S (1994) Case-control surveillance. In: Strom BL, ed. Pharmacoepidemiology, 2nd edn. Chichester, UK: John Wiley and Sons, pp. 301\u2013322.","edition":"2nd edn."},{"key":"255531_CR17","doi-asserted-by":"crossref","first-page":"11301","DOI":"10.1073\/pnas.95.19.11301","volume":"95","author":"J Ruscho","year":"1998","unstructured":"Ruscho. J, Wallinger S, Dietmaier W, et al. (1998) Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci USA\n95: 11301\u201311306.","journal-title":"Proc Natl Acad Sci USA"},{"key":"255531_CR18","first-page":"5473","volume":"58","author":"WE Karnes Jr","year":"1998","unstructured":"Karnes WE Jr, Shattuck-Brandt R, Burgard LJ, et al. (1998) Reduced COX-2 protein in colorectal cancer with defective mismatch repair. Cancer Res\n58: 5473\u20135477.","journal-title":"Cancer Res"},{"key":"255531_CR19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0016-5085(91)90519-Q","volume":"101","author":"D Labayle","year":"1991","unstructured":"Labayle D, Fischer D, Vielh P, et al. (1991) Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology\n101: 635\u2013639.","journal-title":"Gastroenterology"},{"key":"255531_CR20","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","volume":"328","author":"FM Giardiello","year":"1993","unstructured":"Giardiello FM, Hamilton SR, Krush AJ, et al. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med\n328: 1313\u20131316.","journal-title":"N Engl J Med"},{"key":"255531_CR21","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/bjs.1800801244","volume":"80","author":"KP Nugent","year":"1993","unstructured":"Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK (1993) Randomized controlled trial of the Effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg\n80: 1618\u20131619.","journal-title":"Br J Surg"},{"key":"255531_CR22","first-page":"1652","volume":"88","author":"LJ Hixson","year":"1993","unstructured":"Hixson LJ, Earnest DL, Fenerty B, Sampliner RE (1993) NSAID Effect on sporadic colon polyps. Am J Gastroenterol\n88: 1652\u20131656.","journal-title":"Am J Gastroenterol"},{"key":"255531_CR23","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0016-5085(95)90206-6","volume":"108","author":"J Ladenheim","year":"1995","unstructured":"Ladenheim J, Garcia G, Titzer D, et al. (1995) Effect of sulindac on sporadic colonic polyps. Gastroenterology\n108: 1083\u20131087.","journal-title":"Gastroenterology"},{"key":"255531_CR24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/gut.40.3.344","volume":"40","author":"N Matsuhashi","year":"1997","unstructured":"Matsuhashi N, Nakajima A, Fukushima Y, Yazaki Y, Oka T (1997) Effects of sulindac on sporadic colorectal adenomatous polyps. Gut\n40: 344\u2013349.","journal-title":"Gut"},{"key":"255531_CR25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.8484121","volume":"260","author":"LA Aaltonen","year":"1993","unstructured":"Aaltonen LA, Peltomaki P, Leach FS, et al. (1993) Clues to the pathogenesis of familial colorectal cancer. Science\n260: 812\u2013816.","journal-title":"Science"},{"key":"255531_CR26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0959-8049(95)00156-D","volume":"31A","author":"GM Petersen","year":"1995","unstructured":"Petersen GM (1995) Genetic epidemiology of colorectal cancer. Eur J Cancer\n31A: 1047\u20131050.","journal-title":"Eur J Cancer"},{"key":"255531_CR27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1469-1809.1994.tb01891.x","volume":"58","author":"C Scapoli","year":"1994","unstructured":"Scapoli C, Ponz de Leon M, Sassatelli R, et al. (1994) Genetic epidemiology of hereditary non-polyposis colorectal cancer syndromes in Modena, Italy: results of a complex segregation analysis. Ann Hum Genet\n58: 275\u2013295.","journal-title":"Ann Hum Genet"},{"key":"255531_CR28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","volume":"81","author":"M Aarnio","year":"1999","unstructured":"Aarnio M, Sankila R, Pukkala E, et al. (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer\n81: 214\u2013218.","journal-title":"Int J Cancer"},{"key":"255531_CR29","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/jnci\/91.11.916","volume":"91","author":"JD Potter","year":"1999","unstructured":"Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst\n91: 916\u2013932.","journal-title":"J Natl Cancer Inst"},{"key":"255531_CR30","first-page":"1186","volume":"14","author":"Anonymous","year":"1999","unstructured":"Anonymous (1999) Early trials probe COX-2 inhibitors' cancerfighting potential. [News] J Natl Cancer Inst\n14: 1186\u20131187.","journal-title":"J Natl Cancer Inst"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1008931708716.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1008931708716\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1008931708716.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:58:27Z","timestamp":1750960707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1008931708716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["255531"],"URL":"https:\/\/doi.org\/10.1023\/a:1008931708716","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}